African Journal of
Pharmacy and Pharmacology

  • Abbreviation: Afr. J. Pharm. Pharmacol.
  • Language: English
  • ISSN: 1996-0816
  • DOI: 10.5897/AJPP
  • Start Year: 2007
  • Published Articles: 2281

Full Length Research Paper

Pakistani physicians’ knowledge and attitude towards reporting adverse drug reactions

Wajiha Iffat
  • Wajiha Iffat
  • Dow College of Pharmacy, Dow University of Health Sciences, Karachi, Pakistan
  • Search for this author on:
  • Google Scholar
Sadia Shakeel
  • Sadia Shakeel
  • Dow College of Pharmacy, Dow University of Health Sciences, Karachi, Pakistan
  • Search for this author on:
  • Google Scholar
Najia Rahim*
  • Najia Rahim*
  • Dow College of Pharmacy, Dow University of Health Sciences, Karachi, Pakistan
  • Search for this author on:
  • Google Scholar
Fakhsheena Anjum
  • Fakhsheena Anjum
  • Dow College of Pharmacy, Dow University of Health Sciences, Karachi, Pakistan
  • Search for this author on:
  • Google Scholar
Shagufta Nesar
  • Shagufta Nesar
  • Department of Pharmaceutics, Faculty of Pharmacy, University of Karachi, Karachi, Pakistan
  • Search for this author on:
  • Google Scholar
Sana Ghayas
  • Sana Ghayas
  • Dow College of Pharmacy, Dow University of Health Sciences, Karachi, Pakistan
  • Search for this author on:
  • Google Scholar


  •  Received: 21 October 2013
  •  Accepted: 07 April 2014
  •  Published: 15 April 2014

References

Ayani I, Aguirre C, Gutiérrez G, Madariaga A, Rodríguez-Sasiaín JM, Martínez-Bengoechea MJ (1999). A cost‐analysis of suspected adverse drug reactions in a hospital emergency ward. Pharmacoepidemiol. Drug Saf. 8(7):529-534.
PubMed
 
Aziz Z, Siang TC, Badarudin NS (2007). Reporting of adverse drug reactions: predictors of under‐reporting in Malaysia. Pharmacoepidemiol. Drug Saf. 16(2):223-228.
Crossref
 
Bateman D, Sanders GL, Rawlins MD (1992). Attitudes to adverse drug reaction reporting in the Northern Region. Br. J. Clin. Pharmacol. 34(5):421.
 
Belton K (1997). Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union. Eur. J. Clin. Pharmacol. 52(6):423-427.
Crossref
 
Brewer T, Colditz GA (1999). Postmarketing surveillance and adverse drug reactions: current perspectives and future needs. JAMA 28:824–829.
Crossref
 
Cosentino M, Leoni O, Banfi F, Lecchini S, Frigo G (1997). Attitudes to adverse drug reaction reporting by medical practitioners in a Northern Italian district. Pharmacol. Res. 35(2):85-88.
Crossref
 
D'arcy P, Griffin J (1994). Thalidomide revisited. Adv. Drug React. Toxicol. Rev. 13(2):65-76.
 
Edwards IR, Aronson JK (2000). Adverse drug reactions: definitions, diagnosis, and management. The Lancet 356(9237):1255-1259.
Crossref
 
Enwere OO, Fawole OI (2008). Adverse drug reactions reporting by physicians in Ibadan, Nigeria. Pharmacoepidemiol. Drug Saf. 17:517-522.
Crossref
 
Ernst FR, Grizzle AJ (2001). Drug-related morbidity and mortality: updating the cost-of-illness model. Japha-Washington 41(2):192-199.
 
Evans SM,Berry JG, DeWit M (2006). Attitudes and barriers to incident reporting: a collaborative hospital study. BMJ Qual. Saf. 15(1):39-43.
Crossref
 
Fadare JO, Enwere O, Afolabi AO, Chedi BAZ, Musa A (2011). Knowledge, attitude and practice of adverse drug reaction reporting among healthcare workers in a tertiary centre in Northern Nigeria. Trop. J. Pharm. Res. 10(3).
Crossref
 
Figueiras A, Tato F, Fontai-as J, Gestal-Otero JJ (1999). Influence of physicians' attitudes on reporting adverse drug events: a case-control study. Med. Care 37(8):809-814.
Crossref
 
Ghulam M, Saeed R, Tahir MA (2013). Adverse Drug Reaction Reporting System at Different Hospitals of Lahore, Pakistan - An Evaluation And Patient Out Come Analysis. J. App. Pharm. 04(01):713-719
 
Ethiopian Drug Administration and Control Authority (DACA) (2008).Guideline for Adverse Drugs Reaction (ADR) Monitoring DACA, Addis Ababa, Ethiopia.
 
Gupta P, Udupa A (2011). Adverse Drug Reaction Reporting and Pharmacovigilance: Knowledge, Attitudes and Perceptions amongst Resident Doctors. J. Pharm. Sci. Res. 3(2).
 
Hazell L, Shakir SA (2006). Under-reporting of adverse drug reactions. Drug Saf. 29(5):385-396.
Crossref
 
Kharkar M, Bowalekar S (2012). Knowledge, attitude and perception/practices (KAP) of medical practitioners in India towards adverse drug reaction (ADR) reporting. Perspect. Clin. Res. 3(3):90.
Crossref
 
Lazarou J, Pomeranz BH, Corey PN (1998).Incidence of adverse drug reactions in hospitalized patients. JAMA 279(15):1200-1205.
Crossref
 
Li Q, Zhang SM, Chen HT, Fang SP, Yu X, Liu D, Shi LY, Zeng FD (2004). Awareness and attitudes of healthcare professionals in Wuhan, China to the reporting of adverse drug reactions. Chin. Med. J. 117(6): 856-861.
 
Lopez-Gonzalez E, Herdeiro MT, Figueiras A (2009). Determinants of under-reporting of adverse drug reactions. Drug Saf. 32(1):19-31.
Crossref
 
Milstein JB, Faich GA, Hsu JP, Knapp DC (1986). Factors affecting physician reporting of adverse drug reactions. Drug Inf. J. 20:157-164.
 
Nichols V, Thériault-Dubé I, Touzin J, Delisle JF, Lebel D, Bussières JF, Bailey B, Collin J (2009). Risk Perception and Reasons for Noncompliance in Pharmacovigilance. Drug Saf. 32(7):579-590.
Crossref
 
Okezie EO (2008). Adverse drug reactions reporting by physicians in Ibadan, Nigeria. Pharmacoepidemiol. Drug Saf. 17(5):517-522.
Crossref
 
Oshikoya KA, Awobusuyi JO (2009). Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria. BMC Pharmacol. Toxicol. 9(1):14.
 
Rawlins MD (1994). Pharmacovigilance: paradise lost, regained or postponed? The William Withering Lecture. J. R Coll Physicians Lond. 29:41–49.
 
Rogers AS, Isreal E, Smith CR, Levine D, McBean AM, Valente C, Faich G (1988). Physician knowledge, attitudes, and behaviour related to reporting adverse drug events. Arch. Intern. Med. 148:1596-1600
Crossref
 
Salehifar E, Ala SH, Gholami KH (2007). Knowledge, attitudes, and perceptions of pharmacists and Nurses ADR reporting in Mazandaran, Iran. Mazandaran Univ. Med. Sci. J. 56:115–125.
 
Smith C, Bennett PM, Pearce HM, Harrison PI, Reynolds DJM, Aronson JK, Grahame Smith DG (1996). Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines. Br. J. Clin. Pharmacol. 42(4):423-429.
Crossref
 
Vallano A, Cereza G, Pedròs C, Agustí A, Danés I, Aguilera C, Arnau JM (2005). Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital. Br. J. Clin. Pharmacol. 60(6):653-658.
Crossref
 
Vessal G, Mardani Z, Mollai M (2009). Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran. Pharm. World Sci. 31(2):183-187.
Crossref
 
Waller PC (2006). Making the most of spontaneous adverse drug reaction reporting. Basic Clin. Pharmacol. Toxicol. 98(3):320-323.
Crossref
 
WHO. Safety Monitoring of Medicinal Products. Guidelines for setting up and running a Pharmacovigilance Centre. World Health Organization and the Uppsala Monitoring Centre, 2000.
 
WHO (2001). A Guideline to detecting and reporting adverse drug reactions, Geneva.
 
WHO (2002). Safety of medicines: A Guideline to detecting and reporting adverse drug reactions, Geneva.
 
Wiffen P, Gill M, Edwards J, Moore A (2002). Adverse drug reactions in hospital patients. A systematic review of the prospective and retrospective studies. Bandolier Extra 1–16.
 
Williams D, Feely J (1999). Under-reporting of adverse drug reactions: attitudes of Irish doctors. Irish J. Med. Sci. 168(4):257-261.
Crossref
 
Wu WK, Pantaleo N (2003). Evaluation of outpatient adverse drug reactions leading to hospitalization. Am. J. Health Syst. Pharm. 60(3):253-259.
 
Yadav S (2008). Status of adverse drug reaction monitoring and pharmacovigilance in selected countries. Indian J. Pharmacol. 40(Suppl1):S4.

 

Copyright © 2024 Author(s) retain the copyright of this article.

This article is published under the terms of the Creative Commons Attribution License 4.0

Back to Vol. 8 No. 14
Back to articles
SUBSCRIBE TO RSS
SUBMIT MANUSCRIPT
CONFERENCES